Health Canada has recalled a single lot of Eli Lilly Glucagon, as it may be contaminated. The lot number is D239382A, expiry May 10, 2022. Please check your glucagon kits and return it to the pharmacy if you have a vial with this lot number. All other lot numbers are fine.
For more information, click here: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76507a-eng.php.
The Government of Alberta achieved an important milestone yesterday by announcing the expansion of public coverage of continuous glucose monitors (CGMs) to all ages, removing the existing age cap. Prior to this announcement, public coverage of CGMs in Alberta did not extend beyond age 18. It is estimated that over 30,000 people live with T1D […]
The leading type 1 diabetes (T1D) research and advocacy organization unveils its new identity to better reflect the community it serves while working to accelerate breakthroughs in T1D research TORONTO, ON, November 1, 2024 – Breakthrough T1D Canada, formerly JDRF Canada, is proud to announce its brand relaunch, featuring a new name and refreshed visual […]
Ottawa, ON (October 11, 2024) – For the more than four million people living with diabetes in Canada, access to affordable medications is critical. As Bill C-64, An Act Respecting Pharmacare, received Royal Assent, we applaud the Government of Canada for taking the initial steps towards the development of a plan to provide coverage for a […]
